Cargando…

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

Although the ever-increasing number of cancer patients pose substantial challenges worldwide, finding a treatment with the highest response rate and the lowest number of side effects is still undergoing research. Compared to chemotherapy, the relatively low side effects of cancer immunotherapy have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseinkhani, Negar, Derakhshani, Afshin, Kooshkaki, Omid, Abdoli Shadbad, Mahdi, Hajiasgharzadeh, Khalil, Baghbanzadeh, Amir, Safarpour, Hossein, Mokhtarzadeh, Ahad, Brunetti, Oronzo, Yue, Simon C., Silvestris, Nicola, Baradaran, Behzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663909/ https://www.ncbi.nlm.nih.gov/pubmed/33167514 http://dx.doi.org/10.3390/ijms21218305

Ejemplares similares

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

A Systematic Review of the Tumor-Infiltrating CD8(+) T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
por: Kooshkaki, Omid, et al.
Publicado: (2020)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2022)

MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
por: Kooshkaki, Omid, et al.
Publicado: (2020)

A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2022)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review
por: Ahangar, Noora Karim, et al.
Publicado: (2021)

Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma
por: Derakhshani, Afshin, et al.
Publicado: (2020)

Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
por: Kooshkaki, Omid, et al.
Publicado: (2020)

The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
por: Hassanian, Hamidreza, et al.
Publicado: (2022)

Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy
por: Amir Taghavi, Bita, et al.
Publicado: (2022)

The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
por: Kooshkaki, Omid, et al.
Publicado: (2020)

Varied functions of immune checkpoints during cancer metastasis
por: Safarzadeh, Ali, et al.
Publicado: (2020)

Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis
por: Derakhshani, Afshin, et al.
Publicado: (2022)

Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs
por: Derakhshani, Afshin, et al.
Publicado: (2021)

From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
por: Makaremi, Shima, et al.
Publicado: (2021)

microRNA‐193a‐5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9
por: Baghbanzadeh, Amir, et al.
Publicado: (2022)

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
por: Fasano, Rossella, et al.
Publicado: (2021)

The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
por: Bolandi, Nadia, et al.
Publicado: (2021)

Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy
por: Derakhshani, Afshin, et al.
Publicado: (2021)

COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
por: Brunetti, Oronzo, et al.
Publicado: (2020)

Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?
por: Gholizadeh, Mahsa, et al.
Publicado: (2021)

miR-146a-5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway
por: Noorolyai, Saeed, et al.
Publicado: (2021)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
por: Ghorbaninezhad, Farid, et al.
Publicado: (2022)

MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study
por: Tebbi, Leila, et al.
Publicado: (2022)

Molecular pathways in the development of HPV-induced cervical cancer
por: Rasi Bonab, Farnaz, et al.
Publicado: (2021)

miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis
por: Mansoori, Behzad, et al.
Publicado: (2021)

MicroRNAs and lncRNAs—A New Layer of Myeloid-Derived Suppressor Cells Regulation
por: Safarzadeh, Elham, et al.
Publicado: (2020)

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
por: Asadzadeh, Zahra, et al.
Publicado: (2020)

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
por: Lotfinejad, Parisa, et al.
Publicado: (2020)

Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment
por: Javadrashid, Darya, et al.
Publicado: (2021)

Alpha7 Nicotinic Acetylcholine Receptor Mediates Nicotine-induced Apoptosis and Cell Cycle Arrest of Hepatocellular Carcinoma HepG2 Cells
por: Hajiasgharzadeh, Khalil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_59quoil292cq788ec5jql3hoo8